✦ LIBER ✦

539 2-YEAR RESULTS OF TELBIVUDINE (LDT) ROADMAP STUDY VERIFY THE OPTIMAL EFFICACY AND SAFETY RESULTS IN HBEAG POSITIVE CHRONIC HEPATITIS B (CHB) PATIENTS

✍ Scribed by T. Piratvisuth; P. Komolmit; T. Tanwandee; W. Sukeepaisarnjaroen; H.L. Chan; M.G. Pessoa; E. Fassio; S. Ono-Nita; F. Bessone; J. Daruich; S. Zeuzem; H. Cheinquer; Y. Dong; A. Trylesinski

Book ID: 117380751
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 62 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(12)60552-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

496 Efficacy and safety of 2 years adefo

496 Efficacy and safety of 2 years adefovir dipivoxil (ADV) in chinese patients with HBeAg positive chronic hepatitis B (CHB)

✍ M.D. Zeng; Y.M. Mao; G.B. Yao; H. Wang; J.L. Hou; Y.Z. Wang; J.S. Dixon; K.E. Ba 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 116 KB

438 Continued safety and efficacy of add

438 Continued safety and efficacy of adding adefovir dipivoxil (ADV) to ongoing lamivudine (LAM) therapy in compensated chronic hepatitis B (CHB) patients with YMDD variant HBV: 2 year results

✍ R. Perrillo; B. Willems; N. Leung; C. Trepo; H.W.L. Hann; G. Lau; W.M. Lee; E. S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB

1181 A phase III, partially double-blind

1181 A phase III, partially double-blinded study evaluating the efficacy and safety of peginterferon alfa-2A (40KD) (PEGSYS®) alone or in combination with lamivudine vs lamivudine in 546 patients with HBEAG-negative/anti-HBE-positive chronic hepatitis B

✍ MARCELLIN, P; LAU, G; BONINO, F; FARCI, P; HADZIYANNIS, S; JIN, R; LU, Z; PIRATV 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

40 kDa peginterferon alfa-2A (PEGASYS®):

40 kDa peginterferon alfa-2A (PEGASYS®): efficacy and safety results from a phase II, randomized, actively controlled, multicenter study in the treatment of HBeAg positive chronic hepatitis B: Graham E Cooksley, Royal Brisbane Hospital, Herston, Queensland Australia; Teerha Piratvisuth, Songklanakarin Hospital, Songkla Thailand; Yuan-Jen Wang, Teipei Veterans General Hospital, Taipei Taiwan; Varocha Mahachai, Chulalongkorn Hospital, Bangkok Thailand; You-Chen Chao, Tri Service General Hosptital, Taipei Taiwan; Tawesak Tanwandee, Siriraj Hospital, Bangkok Thailand; Anuchit Chutaputti, Pramongkutklao Hospital, Bangkok Thailand; Wen Yu Chang, Kaohsiung University Hospital, Kaohsiung Taiwan; Friederike E Zahm, Hoffmann-La Roche Basel Switzerland; Nigel Pluck, Roche Products Ltd, Welwyn Uk

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB